Regions Financial Corp’s Myriad Genetics MYGN Stock Holding History

Regions Financial Corp’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-36,365	Closed	-$1.29M	–	932
2015 Q1	$1.29M	Buy	36,365 +198	+0.5%	+$7.09K	0.02%	445
2014 Q4	$1.23M	Buy	36,167 +233	+0.6%	+$8.27K	0.02%	461
2014 Q3	$1.39M	Buy	35,934 +1,123	+3%	+$41.9K	0.02%	485
2014 Q2	$1.35M	Buy	34,811 +2,223	+7%	+$82.7K	0.02%	497
2014 Q1	$1.11M	Buy	32,588 +3,007	+10%	+$93.2K	0.01%	548
2013 Q4	$621K	Sell	29,581 -15,058	-34%	-$381K	0.01%	709
2013 Q3	$1.05M	Buy	44,639 +9,128	+26%	+$259K	0.01%	516
2013 Q2	$954K	Buy	+35,511	New	+$1.03M	0.01%	513

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Regions Financial Corp's MYGN Position: Q2 2015 in Review

Regions Financial Corp sold out of Myriad Genetics (MYGN) in Q2 2015, closing a stake of 36,365 shares — an estimated $1.29M sold.

Regions Financial Corp first reported a position in MYGN in Q2 2013 and held it in 8 quarters. The position peaked at $1.39M in Q3 2014. 234 funds tracked by Wall St. Rank hold MYGN as of Q2 2015.

Regions Financial Corp reported no remaining Myriad Genetics position as of Q2 2015 after selling out during the quarter.
Regions Financial Corp sold 36,365 Myriad Genetics shares in Q2 2015, an estimated $1.29M.
Regions Financial Corp first reported a position in Myriad Genetics in Q2 2013 and held it in 8 quarters.
Regions Financial Corp's Myriad Genetics position peaked at $1.39M in Q3 2014.
234 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2015.

Based on Regions Financial Corp's 13F filing for Q2 2015, filed 14 Jul 2015.